| Name | 3-(5-bromopyrimidin-2-yl)oxy-1-azabicyclo[2.2.2]octane |
|---|
| Molecular Formula | C11H14BrN3O |
|---|---|
| Molecular Weight | 284.15200 |
| Exact Mass | 283.03200 |
| PSA | 38.25000 |
| LogP | 1.65000 |
|
~71%
669770-59-6 |
| Literature: Abbott Laboratories Patent: US2005/137226 A1, 2005 ; Location in patent: Page/Page column 29 ; US 20050137226 A1 |
|
~%
669770-59-6 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/22556 A1, 2004 ; Location in patent: Page 16 ; WO 2004/022556 A1 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |